CT Screening in the Age of Health Care Reform
With the conclusion of the National Lung Screening Trial (NLST) and release of new NCCN guidelines pointing toward increased application of Low Dose CT Screening for high risk lung cancer patients, the question looms: What will this look like in the rapidly evolving healthcare environment?
Please join us for an interactive discussion on potential clinical, practice andeconomic ramifications of changes in LDCT screening practices. Panel memberswill provide insight on emerging recommendations, establishment of ascreening program, and anticipated coverage changes.
This symposium aims to present and discuss:
• Evolution of guidelines following the NLST trial
• Suggested practices for establishing a local screening program
• Changes in reimbursement and potential impact of Health Care Reform